Protalix BioTherapeutics Inc (PLX)
1.21
+0.01
(+0.83%)
USD |
NYAM |
Apr 24, 16:00
1.215
0.00 (0.00%)
Pre-Market: 20:00
Protalix BioTherapeutics Cash from Investing (TTM): -16.71M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -16.71M |
| September 30, 2023 | -11.42M |
| June 30, 2023 | 15.38M |
| March 31, 2023 | 15.95M |
| December 31, 2022 | -5.035M |
| September 30, 2022 | 27.45M |
| June 30, 2022 | 26.16M |
| March 31, 2022 | 33.35M |
| December 31, 2021 | 18.92M |
| September 30, 2021 | -10.92M |
| June 30, 2021 | -7.749M |
| March 31, 2021 | -15.56M |
| December 31, 2020 | -19.95M |
| September 30, 2020 | -27.52M |
| June 30, 2020 | -35.76M |
| March 31, 2020 | -35.59M |
| December 31, 2019 | -0.883M |
| September 30, 2019 | -0.828M |
| June 30, 2019 | -0.61M |
| March 31, 2019 | -0.634M |
| December 31, 2018 | -0.591M |
| September 30, 2018 | -0.709M |
| June 30, 2018 | -0.597M |
| March 31, 2018 | -1.164M |
| December 31, 2017 | -1.119M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.327M |
| June 30, 2017 | -1.277M |
| March 31, 2017 | -0.957M |
| December 31, 2016 | -0.967M |
| September 30, 2016 | 39.18M |
| June 30, 2016 | 39.08M |
| March 31, 2016 | 39.19M |
| December 31, 2015 | 39.39M |
| September 30, 2015 | -0.685M |
| June 30, 2015 | -0.783M |
| March 31, 2015 | -0.73M |
| December 31, 2014 | -1.001M |
| September 30, 2014 | -1.103M |
| June 30, 2014 | -1.255M |
| March 31, 2014 | -1.783M |
| December 31, 2013 | -2.102M |
| September 30, 2013 | -2.207M |
| June 30, 2013 | -2.607M |
| March 31, 2013 | -2.123M |
| December 31, 2012 | -2.286M |
| September 30, 2012 | -2.657M |
| June 30, 2012 | -2.866M |
| March 31, 2012 | -4.07M |
| December 31, 2011 | -5.868M |
| September 30, 2011 | -6.196M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-35.76M
Minimum
Jun 2020
33.35M
Maximum
Mar 2022
-2.701M
Average
-5.035M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
| Agenus Inc | 3.40M |
| InfuSystems Holdings Inc | -6.734M |
| Corbus Pharmaceuticals Holdings Inc | 35.64M |
| AIM ImmunoTech Inc | -0.832M |
| Armata Pharmaceuticals Inc | -8.134M |